Determination of thiazole-4-carboxamide adenine dinucleotide (TAD) levels in mononuclear cells of leukemic patients treated with tiazofurin
- 1 January 1991
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 41 (2), 281-286
- https://doi.org/10.1016/0006-2952(91)90487-p
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Clinical and molecular impact of inhibition of IMP dehydrogenase activity by tiazofurinAdvances in Enzyme Regulation, 1989
- Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemiaAdvances in Enzyme Regulation, 1988
- Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells.Journal of Clinical Investigation, 1985
- Studies on the mechanism of action of 2-β-d-ribofuranosylthiazole-4-carboxamide—VBiochemical Pharmacology, 1984
- Studies on the mechanism of action of tiazofurin metabolism to an analog of NAD with potent IMP dehydrogenase-inhibitory activityAdvances in Enzyme Regulation, 1983
- Studies on the mechanism of action of 2-β-d-ribofuranosylthiazole-4-carboxamide (NSC 286193)-IIBiochemical Pharmacology, 1982
- Mechanism of resistance to the oncolytic C-nucleoside 2-β-D-ribofuranosylthiazole-4-carboxamide (NSC-286193)Biochemical Pharmacology, 1982
- Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-β-d-ribofuranosylthiazole-4-carboxamide NSC 286193)Biochemical Pharmacology, 1982
- The conversion of 2-β-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory propertiesBiochemical Pharmacology, 1982
- 2-.beta.-D-ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastasesJournal of Medicinal Chemistry, 1982